Smith & Nephew plc Logo

Smith & Nephew plc (SNNUF)

OTC

Currency in USD
15.48
0.00 (0.00%)

Closed

Aug 21, 2026

Day's Range

15.48
15.48

52 wk Range

13.10
18.50

Overview - SNNUF - Smith & Nephew plc

Key Statistics

Valuation

Enterprise Value

16.20B

P/E (Trailing)

‪20.91‬

P/E (Forward)

‪15.17‬

PEG Ratio

‪-18.93‬

Price / Sales (TTM)

‪2.05‬

Price / Book

‪2.54‬

EV / EBITDA

‪11.72‬

Profitability

Gross Margin

‪75.26%‬

Profit Margin

‪10.07%‬

Operating Margin

‪14.46%‬

Return on Assets

‪5.15%‬

Return on Equity

‪11.85%‬

Ownership

Shares Outstanding

849.36M

Float

841.90M

Held by Insiders

‪0.23%‬

Held by Institutions

‪75.95%‬

Price stats

Beta

‪0.68‬

50-Day Avg

‪14.37‬

200-Day Avg

‪15.67‬

Dividends

Payout Ratio

‪53.20%‬

Frequency

Semi-Annual

Shariah Compliance

Not Shariah Compliant

Report Date: Feb 16, 2025

Screened by Zoya using the AAOIFI methodology.

Market Cap - SNNUF - Smith & Nephew plc

Peers - SNNUF - Smith & Nephew plc

Peer Comparison

Compared with companies in Medical Devices listed on OTC.

Profile Summary - SNNUF - Smith & Nephew plc

About

Smith & Nephew plc is a British multinational medical technology company specializing in the repair, regeneration, and replacement of soft and hard tissue. Headquartered in Watford, England, it develops and manufactures advanced products across three core business units: Advanced Wound Management for treating chronic…

SectorHealthcare
IndustryMedical Devices
Employees17K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.